{"id":"tiquizium","rwe":[],"tags":[{"label":"tiquizium","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"},{"label":"Abdominal pain","category":"indication"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"thiaton","offLabel":[],"synonyms":["tiquizium","tiquizium bromide","thiaton","HSR-902"],"timeline":[],"approvals":[],"brandName":"Thiaton","ecosystem":[{"indication":"Abdominal pain","otherDrugs":[],"globalPrevalence":null}],"mechanism":{"modality":"Small Molecule","drugClass":"tiquizium","explanation":"Imagine your body has a messaging system that sends pain signals to your brain. Thiaton helps block these pain messages, making you feel less pain. This is done by binding to a specific protein that is involved in sending these pain signals.","oneSentence":"Thiaton works by interacting with a specific molecular target to reduce pain signals in the body.","technicalDetail":"Tiquizium is a small molecule that acts as a ligand for a specific G protein-coupled receptor, modulating the downstream signaling pathway to reduce pain perception."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/2678","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=TIQUIZIUM","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T16:00:45.342282","biosimilars":[],"competitors":[],"genericName":"tiquizium","indications":{"approved":[{"name":"Abdominal pain","source":"DrugCentral","snomedId":21522001,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"340Q44041A","CHEBI":"CHEBI:32232","INN_ID":"5190","UMLSCUI":"C0145974","ChEMBL_ID":"CHEMBL1872078","KEGG_DRUG":"D01875","PUBCHEM_CID":"72160","SECONDARY_CAS_RN":"149755-23-7","MESH_SUPPLEMENTAL_RECORD_UI":"C030950"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Pain"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Thiaton, also known as Tiquizium, is a small molecule drug in the tiquizium class. It is used to treat abdominal pain, but its exact target is unknown. The commercial status of Thiaton is unclear, and it is not known whether it is patented or available as a generic medication. Further information on its pharmacokinetics, such as half-life and bioavailability, is also lacking. As a result, key safety considerations and potential side effects are not well established.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":false,"score":2}}